Homocysteine levels and glucose metabolism in non‐obese, non‐diabetic chronic schizophrenia
- 24 August 2005
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 113 (2) , 121-125
Abstract
Objective: We studied a sample of schizophrenia out‐patients to test the hypotheses that serum homocysteine concentrations would correlate positively with measures of glucose metabolism. Method: Subjects underwent a nutritional assessment and fasting plasma, serum insulin and homocysteine tests. Results: Males had a significantly higher homocysteine levels than females (7.69 ± 1.42 μ m vs. 6.63 ± 1.40 μ m ; P = 0.02). Comparing subjects with normal fasting glucose (NFG) (glucose μ m ) had significantly higher homocysteine levels than those with NFG (mean 7.2 ± 1.4 μ m , P = 0.03). IFG was also associated with greater mean values for a Homeostatic Model Assessment‐Insulin Resistance (HOMA‐IR) ( P = 0.002) and diastolic blood pressure ( P = 0.045). Conclusion: The group with IFG had higher fasting serum homocysteine concentrations than those with NFG which supports a connection to an important cardiovascular risk factor.Keywords
This publication has 28 references indexed in Scilit:
- Elevated Homocysteine Levels in Young Male Patients With SchizophreniaAmerican Journal of Psychiatry, 2002
- Elevated plasma total homocysteine levels in hyperinsulinemic obese subjectsThe Journal of Nutritional Biochemistry, 2002
- Simplified Measurement of Insulin Sensitivity with the Minimal Model Procedure in Type 2 Diabetic Patients without Measurement of InsulinemiaHormone and Metabolic Research, 2002
- Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variantNeuroReport, 1999
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project1997
- Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular diseaseMetabolism, 1996
- Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine StudyJAMA, 1995
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes1995
- Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 YearsBritish Journal of Nutrition, 1974